Polimed is a company focused on the novel medical technologies for treating ultimate cardio- and neurovascular conditions with revenue exceeding $10M. We focus on structural heart disease, ACS interventions, stroke prevention & post-stroke therapies, neurovascular interventions, neurostimulation and therapeutic hypothermia. Our succesfull introductions include: first DES coated w/ biodegradeable polimer, AF balloon cryoablation, LAA occluders (both PLAATO & Watchman), ONYX for treatment of giant aneurysms, intravascular therapeutic hypothermia…
Company’s Keywords:
<3
<
<2003